Goldman Sachs’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $100M | Buy |
579,400
+229,200
| +65% | +$47M | 0.01% | 1020 |
|
|
2025
Q4 | $89.7M | Buy |
350,200
+91,100
| +35% | +$23.9M | 0.01% | 1067 |
|
|
2025
Q3 | $67.4M | Sell |
259,100
-106,700
| -29% | -$28.1M | 0.01% | 1204 |
|
|
2025
Q2 | $89.4M | Sell |
365,800
-18,300
| -5% | -$4.56M | 0.01% | 953 |
|
|
2025
Q1 | $102M | Buy |
384,100
+294,100
| +327% | +$79.5M | 0.02% | 773 |
|
|
2024
Q4 | $22.8M | Buy |
90,000
+50,700
| +129% | +$13.6M | ﹤0.01% | 2005 |
|
|
2024
Q3 | $12.4M | Buy |
39,300
+38,400
| +4,267% | +$13.7M | ﹤0.01% | 2503 |
|
|
2024
Q2 | $336K | Hold |
900
| – | – | ﹤0.01% | 5038 |
|
|
2024
Q1 | $312K | Sell |
900
-22,500
| -96% | -$8.53M | ﹤0.01% | 4955 |
|
|
2023
Q4 | $10.7M | Buy |
23,400
+22,500
| +2,500% | +$11.1M | ﹤0.01% | 2460 |
|
|
2023
Q3 | $438K | Buy |
+900
| New | +$423K | ﹤0.01% | 4710 |
|
|
2021
Q1 | – | Sell |
-26,900
| Closed | -$11M | – | 6184 |
|
|
2020
Q4 | $11M | Sell |
26,900
-4,400
| -14% | -$1.83M | ﹤0.01% | 2376 |
|
|
2020
Q3 | $13M | Buy |
31,300
+400
| +1% | +$161K | ﹤0.01% | 2089 |
|
|
2020
Q2 | $12M | Buy |
30,900
+29,300
| +1,831% | +$11M | ﹤0.01% | 2129 |
|
|
2020
Q1 | $502K | Sell |
1,600
-23,000
| -93% | -$7.76M | ﹤0.01% | 4214 |
|
|
2019
Q4 | $9.02M | Buy |
24,600
+11,700
| +91% | +$3.71M | ﹤0.01% | 2508 |
|
|
2019
Q3 | $3.3M | Buy |
+12,900
| New | +$3.62M | ﹤0.01% | 3168 |
|
|
2019
Q2 | – | Sell |
-18,000
| Closed | -$4.79M | – | 5222 |
|
|
2019
Q1 | $4.79M | Buy |
18,000
+12,100
| +205% | +$3.49M | ﹤0.01% | 3002 |
|
|
2018
Q4 | $1.69M | Sell |
5,900
-58,000
| -91% | -$18.4M | ﹤0.01% | 3630 |
|
|
2018
Q3 | $21.6M | Buy |
63,900
+45,900
| +255% | +$14.9M | 0.01% | 1850 |
|
|
2018
Q2 | $5.36M | Buy |
18,000
+10,000
| +125% | +$2.93M | ﹤0.01% | 2919 |
|
|
2018
Q1 | $2.15M | Sell |
8,000
-8,900
| -53% | -$2.41M | ﹤0.01% | 3548 |
|
|
2017
Q4 | $4.19M | Sell |
16,900
-3,400
| -17% | -$840K | ﹤0.01% | 3172 |
|
|
2017
Q3 | $4.95M | Sell |
20,300
-219,800
| -92% | -$53.9M | ﹤0.01% | 3152 |
|
|
2017
Q2 | $57.8M | Buy |
240,100
+105,600
| +79% | +$23.9M | 0.01% | 1140 |
|
|
2017
Q1 | $27.7M | Sell |
134,500
-333,300
| -71% | -$68.9M | 0.01% | 1661 |
|
|
2016
Q4 | $95.4M | Buy |
467,800
+76,600
| +20% | +$14.6M | 0.03% | 806 |
|
|
2016
Q3 | $69.2M | Buy |
391,200
+250,100
| +177% | +$43.4M | 0.02% | 968 |
|
|
2016
Q2 | $25.4M | Sell |
141,100
-242,700
| -63% | -$43.1M | 0.01% | 1616 |
|
|
2016
Q1 | $70.2M | Buy |
383,800
+256,600
| +202% | +$44.5M | 0.02% | 848 |
|
|
2015
Q4 | $22.7M | Sell |
127,200
-75,300
| -37% | -$13.2M | 0.01% | 1676 |
|
|
2015
Q3 | $36.2M | Sell |
202,500
-84,800
| -30% | -$15.7M | 0.01% | 1278 |
|
|
2015
Q2 | $55M | Buy |
287,300
+142,700
| +99% | +$26.5M | 0.02% | 1055 |
|
|
2015
Q1 | $25.7M | Sell |
144,600
-325,000
| -69% | -$51.4M | 0.01% | 1576 |
|
|
2014
Q4 | $67.4M | Sell |
469,600
-14,400
| -3% | -$1.97M | 0.02% | 894 |
|
|
2014
Q3 | $63.1M | Sell |
484,000
-214,700
| -31% | -$27.3M | 0.02% | 909 |
|
|
2014
Q2 | $89.2M | Sell |
698,700
-10,000
| -1% | -$1.18M | 0.03% | 731 |
|
|
2014
Q1 | $79.9M | Buy |
708,700
+206,200
| +41% | +$21.5M | 0.03% | 730 |
|
|
2013
Q4 | $51.9M | Buy |
502,500
+343,600
| +216% | +$33.7M | 0.02% | 1013 |
|
|
2013
Q3 | $14.8M | Sell |
158,900
-166,700
| -51% | -$15.3M | 0.01% | 1860 |
|
|
2013
Q2 | $27.5M | Buy |
+325,600
| New | +$25.7M | 0.01% | 1298 |
|
Other funds holding HUM
VCM
VPM
SC
Goldman Sachs's HUM Position: Q1 2026 in Review
Goldman Sachs increased its Humana (HUM) stake by 95% in Q1 2026, buying an estimated $190M and bringing the position to 1,905,894 shares worth $330M. The position accounts for 0.04% of the portfolio, ranked #471.
Goldman Sachs first reported a position in HUM in Q2 2013 and has held it in 52 quarters since. The position peaked at $924M in Q1 2017. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.
- Goldman Sachs held 1,905,894 shares of Humana worth $330M as of Q1 2026.
- Goldman Sachs bought 926,389 Humana shares in Q1 2026, an estimated $190M.
- Humana made up 0.04% of Goldman Sachs's portfolio in Q1 2026, its #471 holding.
- Goldman Sachs first reported a position in Humana in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Humana position peaked at $924M in Q1 2017.
- 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.